 |
|
|
| |
Safety and Efficacy of Elbasvir and Grazoprevir with or without Ribavirin for the Treatment of HCV Genotype 1: Results of the HCV-TARGET Study
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Pearlman, BL; Lutchman, G; Shiffman, ML; Patel, J; Frazier, LM; Galati, JS; Gallant, JE; Ramani, A; Vainorius, M; Nelson, DR; Fried, MW; Dong, M; Khalili, M; Ben-Ari, Z
|
| |
|
|
|
|
|
